AstraZeneca coronavirus vaccine early results ‘good news’ but ‘more analysis needed,’ experts say
Following Monday’s news of AstraZeneca and Oxford University’s announcement that their coronavirus vaccine was up to 90% effective in late-stage trials, top experts say the preliminary findings are good news but await further analysis. “The interim analysis supports vaccine safety with no severe reactions to the vaccine and that is good news,” Dr. Andrea Cox, immunologist and professor of medicine at […]
Continue Reading